TOFACITINIB
tofacitinib 5 mg tablet, 56
TOFACITINIB (13737B)
13737B
Manner of administration:Oral
Restriction (Streamlined authority code: 17707)
Indication: Severe active juvenile idiopathic arthritis
Treatment phase: Continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 56 | # of repeats: 5 | DPMQ: $1,155.38 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Xeljanz | |||||